Kravish Pharmaceutical Private Limited

Kravish Pharmaceutical Private Limited - pharma in Thane, Maharashtra, India. Directors, charges & compliance details.
CIN U51909MH2022PTC379392 Incorporated 29 March 2022 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Data last updated
Revenue · FY 2024
₹30.89 Lakh
▲ 219% YoY
Net loss · FY 2024
₹88,267
Net margin -2.9%
EBITDA · FY 2024
₹19,530
EBITDA margin 0.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Kravish Pharmaceutical Private Limited

Data last updated:

Kravish Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 March 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2022PTC379392.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shalini Pandey and Karuna Shanker Pandey.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 604 Wing B1 Flr No 6 Park Woods Ghodbunder Road Nr Batata Factory, Thane, Maharashtra, India – 400607.

As per the financials filed for FY 2024, the company reported a revenue of ₹30.89 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹88,267 (net margin -2.9%) and EBITDA of ₹19,530 (EBITDA margin 0.6%).

Kravish Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0045242).

Company details

CIN U51909MH2022PTC379392
Registration Number 379392
Incorporation Date 29 March 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0045242

Recognitions & Rankings of Kravish Pharmaceutical

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-UP-50-0045242

Contact details

Kravish Pharmaceutical Private Limited's registered office is in Thane, Maharashtra.

  • Registered Address
    Flat No 604 Wing B1 Flr No 6 Park Woods Ghodbunder Road Nr Batata Factory, Thane, Maharashtra, India – 400607
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Kravish Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Kravish Pharmaceutical is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Kravish Pharmaceutical Private Limited, buy the company report.

Financials of Kravish Pharmaceutical Private Limited

FY 2025 filings available

Kravish Pharmaceutical Private Limited reported revenue of ₹30.89 Lakh (up 219% YoY) for FY 2024.

Revenue · FY 2024
₹30.89 Lakh ▲ 219%
Net loss · FY 2024
₹88,267 margin -2.9%
EBITDA · FY 2024
₹19,530 margin 0.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 219%
EBITDA CAGR growth
1 year
▲ 201%

Revenue rose 219% in the latest year. EBITDA rose 201% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹19,530
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹88,267
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin0.6%
Net Profit Margin-2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Kravish Pharmaceutical Private Limited, buy the company report.

Board of directors of Kravish Pharmaceutical Private Limited

Kravish Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shalini PandeyDirector01 Jul 20224 Years 4 MonthsCurrent
Karuna Shanker PandeyDirector29 Mar 20224 Years 7 MonthsCurrent

Peer comparison

Kravish Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Greenkare Agro (OPC) Private Limited₹31.45 Lakh (FY 2025)-33.0%Indapur, Maharashtra, India
Homecoat (OPC) Private Limited₹31.45 Lakh (FY 2025)-53.0%New Panvel, Maharashtra, India
Davidson Remedies Private Limited₹31.38 Lakh (FY 2025)-61.0%Vadodara, Gujarat, India
Shree Balaji Protech Private Limited₹31.18 Lakh (FY 2024)420.0%Ahmedabad, Gujarat, India
Green Cotech Private Limited₹31.07 Lakh (FY 2025)Ludhiana, Punjab, India
Kravish Pharmaceutical Private Limitedthis company₹30.89 Lakh (FY 2024)-₹88,267-2.9%219.0%Thane, Maharashtra, India
RX Plus Pharmaceuticals Private Limited₹30.63 Lakh (FY 2025)10.0%New Delhi, Delhi, India
Waterline Herbal Cosmetics Private Limited₹30.41 Lakh (FY 2025)587.0%Pune, Maharashtra, India
Rimedile Pharmaceutical Private Limited₹30.32 Lakh (FY 2024)72.0%Ghaziabad, Uttar Pradesh, India
Yera Pharmaceuticals Private Limited₹30.2 Lakh (FY 2024)6.0%Pune, Maharashtra, India
Beingkind Healthcare Private Limited₹28.84 Lakh (FY 2025)18996.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Kravish Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Kravish Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Kravish Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Kravish Pharmaceutical Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Bhoori Singh Dhakrey ceased to be Director on 01 Jul 2022.

AGM
Kravish Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kravish Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Bhoori Singh Dhakrey ceased to be Director.
Appointed
Shalini Pandey was appointed as Director.
Appointed
Karuna Shanker Pandey was appointed as Director.
Incorporation
29 Mar 2022
Kravish Pharmaceutical Private Limited was registered on 29 Mar 2022 with Roc Mumbai & aged 4 years 7 months as per MCA records.

Frequently asked questions

Kravish Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 March 2022 (4+ years old) and is registered under CIN U51909MH2022PTC379392.

Kravish Pharmaceutical has 2 current directors:

The latest financial statements of Kravish Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Kravish Pharmaceutical is U51909MH2022PTC379392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kravish Pharmaceutical was incorporated on 29 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Kravish Pharmaceutical by revenue are Greenkare Agro (OPC) Private Limited, Homecoat (OPC) Private Limited, Davidson Remedies Private Limited, Shree Balaji Protech Private Limited, Green Cotech Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).

Bhoori Singh Dhakrey ceased to be Director on 01 Jul 2022. Shalini Pandey was appointed as Director on 01 Jul 2022. Karuna Shanker Pandey was appointed as Director on 29 Mar 2022.

Yes, Kravish Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Kravish Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0045242).

The registered office of Kravish Pharmaceutical is at Flat No 604 Wing B1 Flr No 6 Park Woods Ghodbunder Road Nr Batata Factory, Thane, Maharashtra, India – 400607.

Kravish Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.